ExoNET for Stroke
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new device called ExoNET, designed to assist stroke survivors with arm movement. The device supports the arm to ease movement, aiming to improve therapy outcomes. Participants will use the ExoNET either with or without gravity support to determine which method is more effective. The trial seeks individuals who had a stroke at least 8 months ago, experience arm weakness on one side, and can move their shoulder and elbow to some extent. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance stroke recovery therapies.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you have had a Botox injection in the affected arm within the last 4 months, you cannot participate.
What prior data suggests that the ExoNET device is safe for stroke patients?
Research has shown that exoskeleton devices like ExoNET are generally safe for stroke patients. One study tested a similar device on six stroke patients and found no serious side effects or safety issues. Another study examined various exoskeletons used for stroke rehabilitation and found them effective without causing harm. These findings suggest that exoskeleton devices, including ExoNET, are safe and well-tolerated for aiding stroke recovery.12345
Why are researchers excited about this trial?
Unlike the standard treatments for stroke, which often involve medication and physical therapy, ExoNET offers a unique approach by using a device that compensates for gravity. This innovative mechanism assists stroke patients in regaining movement more naturally by reducing the physical effort required to move their limbs. Researchers are excited about ExoNET because it might enhance rehabilitation outcomes by enabling more effective and sustained practice of motor skills, potentially speeding up recovery and improving overall mobility.
What evidence suggests that the ExoNET device is effective for stroke rehabilitation?
Research has shown that the ExoNET device could aid recovery after a stroke. In this trial, participants in the experimental group will use the ExoNET device, which provides gravity compensation to assist in lifting the arm, helping stroke patients regain strength and movement. One study found that ExoNET's support system is safe and practical, aiding patients in relearning movement. Early results indicate that ExoNET can effectively address movement problems in stroke survivors, suggesting that the device could improve arm function in these individuals.678910
Are You a Good Fit for This Trial?
This trial is for adults who have had a stroke at least 8 months ago and now experience moderate arm weakness (hemiparesis). They should be able to move their shoulder and elbow somewhat but can't join if they have pain or stiffness in the joints, severe muscle tightness, recent Botox treatments in the arm, or problems with understanding that would affect participation.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Evaluation
Baseline evaluations including Fugl-Meyer, Wolf Motor Function Test, Action Research Arm Test, and Box and Blocks
Treatment
Participants perform reaching, arm elevation, and flexion task exercises wearing the ExoNET device
Post Evaluation
Post evaluations including Fugl-Meyer, Wolf Motor Function Test, Action Research Arm Test, and Box and Blocks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- ExoNET
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shirley Ryan AbilityLab
Lead Sponsor